B / 32 : Drugs Used In Cancer Treatment Iv (Hormonal Agents) Flashcards
When can hormone therapy be used in cancer?
For hormone dependent cancers, for example : prostate cancer grows faster with more testosterone
What are the anti-estrogen drugs?
Tamoxifen
Tamoxifen
- MOA
- Effect
- Indication
- SE
- ROA
- Estrogen receptor ANTagonist in BREAST, AGonist in ENDOMETRIUM, partial AGonist in bones
- For treatment of breast cancer + prevention after surgery
- Hot flashes, hyperplasia, polyps, increased risk of endometrial cancer
- Oral
What is an example of an aromatase inhibitor?
Anastrozole
What are the types of hormonal agents used in cancer treatment? (5)
- Anti estrogens
- Aromatase inhibitors
- LH analogs
- Anti-androgens
- Glucocorticoids + somatostatin analogs
Anastrozole
- MOA
- Effect
- Indication
- SE
- ROA
- Aromatase (non steroidal) inhibitor
- Prevents conversion of testosterone to estrogen
- For treatment of hormone dependent breast cancer in post menopausal women
- Hot flashes, vaginal dryness, risk of osteoporosis and cardiovascular diseases
- Oralé
What is the role of the aromatase enzyme?
Conversion of testosterone to estrogen
What are the LH analogs?
- Goserelin
- Degarelix
Goserelin
- MOA
- Effect
- Indication
- SE
- ROA
- Synthetic peptide with GnRH AGonist activity
- Depends on the dose
- Pulsatile : for induction of ovulation / Continuous : endometriosis, tumors
- Women : vaginal dryness, breast atrophy / men : edema, anemia
- Parenteral
Degarelix
- MOA
- Effect
- Indication
- ROA
- GnRH ANTagonist
- Suppress endogenous LH and FSH
- Prostate cancer
- Parenteral
What is an example of an anti-androgen
BIcalutamide
Bicalutamide
- MOA
- Effect
- Indication
- SE
- ROA
- Androgen receptor inhibitor
- Decreases testosterone
- For prostate cancer
- Gonadal atrophy, gynecomastia, infertility
- Oral
What are the glucocorticoid / somatostatin analogs?
- Prednisolone (glucocorticoids)
- Ocreotide (somatostatin)
Prednisolone
- MOA
- Effect
- Indication
- ROA
- Glucocorticoid analog
- Alter gene expression + anti-inflammatory and immunosuppressive effects
- For Hodgkin and non Hodgkin lymphomas, acute leukemias
- Oral, Topical, IV
Ocreotide
- MOA
- Effect
- Indication
- SE
- ROA
- Somatostatin analog
- Inhibit release of GH, insulin, glucagon, gastrin : decrease GI function
- For endocrine tumors
- GI, steatorrhea
- Parenteral